Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) for Assessing Tumour Resectability in Advanced Epithelial Ovarian/fallopian Tube/primary Peritoneal Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435687/all/images/tooltip-triangle.png. Accessed 27 April 2024.
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435687/all/images/tooltip-triangle.png. Accessed April 27, 2024.
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435687/all/images/tooltip-triangle.png
Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) for Assessing Tumour Resectability in Advanced Epithelial Ovarian/fallopian Tube/primary Peritoneal Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435687/all/images/tooltip-triangle.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/fallopian tube/primary peritoneal cancer
ID - 435687
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435687/all/images/tooltip-triangle.png
DB - Evidence Central
DP - Unbound Medicine
ER -